By serving as a prioritization layer in the clinical workflow, AI tools can help radiologists focus their expertise on the most suspicious cases in high-volume screening environments. This necessity has become increasingly clear as medical imaging volumes continue to expand, placing immense
High-performance AI models often suffer from poor generalizability when they are validated on only a single, narrow dataset from one institution. This limitation poses a significant hurdle in neuro-oncology, where the stakes for accurate diagnosis are exceptionally high. In the United States, the
Oncologists are now utilizing AI to auto-draw radiation zones for tumors, yet the ecological footprint of this technology is rarely discussed within the high-pressure environment of a clinical setting. As artificial intelligence becomes an inextricable part of modern medical research and practice,
A collaborative team from MIT and Harvard has developed a technique called xvr to bridge the dangerous gap between real-time X-rays and preoperative 3D scans. Surgeons navigating the complex pathways of the human vascular system or delicate neurological structures often rely on two-dimensional
Sophisticated data manipulation strikes at both the input and output of a system, potentially collapsing the ethical principles of autonomy and non-maleficence. The integration of artificial intelligence into medical imaging represents a transformative shift in healthcare, moving from experimental
Standard 120 kVp images often lack the necessary contrast to expose the physiological differences between well-differentiated and poorly-differentiated neoplasms. This inherent limitation in conventional imaging makes the differentiation of pancreatic neuroendocrine neoplasms one of the most
